Dr Christopher Gallen has been appointed president and CEO of Vancouver-based Neuromed Technologies Inc, a private biopharmaceutical firm focused on drugs for chronic pain. He replaces founding president
Person: Dr Christopher Gallen
Natalie Dakers
Natalie Dakers (see below), who helped the firm move through Phase I clinical trials and raise $70 million in venture capital financing. Gallen was most recently with Wyeth Research where he held the posi
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...